ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 936

Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand

Daniel Glinatsi1, Paul Bird2, Frédérique Gandjbakhch3,4, Espen A. Haavardsholm5, Philip G. Conaghan6 and Mikkel Østergaard7, 1Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, Glostrup, Denmark, 2Medicine, University of New South Wales, Sydney, NSW, Australia, 3Service de Rhumatologie, GH Pitié-Salpétrière, MD, Paris, France, 4Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, 5Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: MRI, rheumatoid arthritis (RA) and tendonitis/bursitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases I: Advanced Imaging in RA and Spondyloarthritides

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Tenosynovitis in the hand occurs frequently and early in rheumatoid arthritis (RA) and sensitive outcome measures are important to assess and monitor the inflammatory activity. Magnetic resonance imaging (MRI) can visualize tenosynovitis and a semiquantitative scoring system for tenosynovitis in the hand has previously been suggested1. In a multi-reader exercise, we aimed to assess the intra- and inter-reader agreement and responsiveness of a proposed OMERACT MRI tenosynovitis scoring system in the wrist and metacarpophalangeal (MCP) flexor tendons in the hands of RA patients.

Methods: Axial T1-weighted pre- and post-contrast fat-sat MRIs (0.8mm slice thickness) of the hand of 43 patients initiating rituximab therapy were obtained at baseline and after 3 (n=5), 6 (n=8), 9 (n=15) or 12 (n=15) months. The MRIs were read and scored twice on separate days with intermediate re-anonymization by 4 readers blinded to patient data but not to chronology. The tendons of 6 extensor and 3 flexor tendon compartments of the wrist and 4 flexor tendon compartments of the 2nd to 5th MCP joints were assessed. Tenosynovitis was defined as peritendinous effusion (PE) or post-contrast tenosynovial enhancement (PTE) on 3 consecutive slices. Pathologies were measured perpendicularly to the tendon at the thickest point of the effused or enhanced tenosynovium. Tenosynovitis was scored as follows: 0: no, 1: >0 but <1.5mm, 2: ≥1.5 but <3mm, 3: ≥3mm PE or PTE. Change in score over time was assessed using descriptive statistics and the Wilcoxon signed-rank test. Intra- and inter-reader agreement was calculated using intra-class correlation coefficients (ICC), percentage of exact and close agreement (PEA and PCA) and the smallest detectable change (SDC). Responsiveness to change was assessed using standardized response mean (SRM).

Results: The mean (SD) change in score between baseline and follow-up was -1.38 (2.84) for wrist, -0.94 (1.85) for MCP flexor tendons and -2.31 (4.63) for total score (all p<0.01). Intra- and inter-reader ICC for status scores were very good in all readers, except baseline scores in the MCP region in 1 reader. Intra-reader ICC for change scores were good to very good in all readers, and inter-reader ICC for status and change scores were very good in all readers. Intra-reader PEA for status and change scores was above 57% and PCA above 95% for all parameters. Inter-reader PEA was above 40% and PCA above 81% for all parameters. Intra-reader SDC was equal or below 3.0 and inter-reader SDC was below 2.0 in all readers. SRM was small to moderate (table 1).

Conclusion: The proposed OMERACT tenosynovitis scoring system showed high intra- and inter-reader agreement and small to moderate responsiveness for the wrist and MCP tendons and is a reliable tool for MRI-assessment of tenosynovitis in the RA hand. 1Haavardsholm et al. Ann Rheum Dis 2007;66(9):1216-20


Disclosure: D. Glinatsi, None; P. Bird, None; F. Gandjbakhch, None; E. A. Haavardsholm, Pfizer Inc, 5,MSD, 5,AbbVie, 2,UCB, 2,MSD, 2,Pfizer Inc, 2,Roche Pharmaceuticals, 2; P. G. Conaghan, None; M. Østergaard, Abbott Immunology Pharmaceuticals, 2,Bristol-Myers Squibb, 2,Boehringer Ingelheim, 2,Eli Lilly and Company, 2,Merck Pharmaceuticals, 2,Pfizer Inc, 2,Roche Pharmaceuticals, 2,UCB, 2,Celgene, 2,Sanofi-Aventis Pharmaceutical, 2,Regeneron, 2,Novartis Pharmaceutical Corporation, 2.

To cite this abstract in AMA style:

Glinatsi D, Bird P, Gandjbakhch F, Haavardsholm EA, Conaghan PG, Østergaard M. Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/reliability-and-responsiveness-of-an-omeract-tenosynovitis-magnetic-resonance-imaging-scoring-system-for-the-rheumatoid-arthritis-wrist-and-hand/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-and-responsiveness-of-an-omeract-tenosynovitis-magnetic-resonance-imaging-scoring-system-for-the-rheumatoid-arthritis-wrist-and-hand/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology